CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference151 articles.
1. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product;Ishino;J. Bacteriol.,1987
2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021
3. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities;Li;Biomaterials,2018
4. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing;Wei;ACS Nano,2020
5. CRISPR provides acquired resistance against viruses in prokaryotes;Barrangou;Science (New York, N.Y.),2007
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, characterization, and cellular investigation of three smart polymeric nanoparticles as efficient plasmid CRISPR (pCRISPR) delivery vehicles;Advances in Natural Sciences: Nanoscience and Nanotechnology;2024-09-06
2. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment;Nanotechnology;2024-07-17
3. Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy;International Journal of Molecular Sciences;2024-07-14
4. Near-infrared light responsive upconversion-DNA nanocapsules for remote-controlled CRISPR-Cas9 genome editing;Chinese Chemical Letters;2024-07
5. Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases;Journal of Nanobiotechnology;2024-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3